Even Avecho Biotechnology (formerly Phosphagenics), a company who wanted to repurposed AOD-9604 as a transdermal formulation, knew why the clinical trials failed: AOD9604s delivery could have been the key issue
Opt for a high quality brand that doesnt contain lots of yucky additives
Improves energy levels and reduces fatigue
A thoughtful consultation can help determine whether peptide therapy belongs in the conversation, whether another medical evaluation should come first, and how to monitor progress if a peptide-related strategy is considered
CD38 and inflammaging CD38, a NAD+-consuming enzyme, becomes more active with age and chronic inflammation
When it comes to CJC 1295 and Ipamorelin, the good news is that they are generally well-tolerated by most people